Telormedix SA

π¨πSwitzerland
- Country
- π¨πSwitzerland
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.telormedix.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 2
1 (100.0%)Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer
Phase 2
Completed
- Conditions
- Carcinoma in SituNon Muscle Invasive Bladder Cancer
- Interventions
- First Posted Date
- 2012-11-22
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- Telormedix SA
- Target Recruit Count
- 12
- Registration Number
- NCT01731652
- Locations
- πΊπΈ
BCG Oncology, Phoenix, Arizona, United States
πΊπΈThe Urology Center of Colorado, Denver, Colorado, United States
πΊπΈUrologic Consultants of SE PA, Bala Cynwyd, Pennsylvania, United States
News
No news found